BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2018
View Archived Issues
Astrocyte-driven inflammation is depression biomarker, target
Read More
Fungus is no fun for asthmatics
Read More
Senescent cells tangle up tau
Read More
PFN2 and GAMT are novel biomarkers of Charcot-Marie-Tooth disease
Read More
Methylation of the tumor suppressor TIPE3 corresponds to worse prognosis in nasopharyngeal carcinoma
Read More
Autoantibodies against TSP-4 are a diagnostic feature of osteoarthritis
Read More
Gilead Sciences presents the discovery of a novel Cyp inhibitor with potent anti-HCV activity
Read More
Phase I/II clinical trial of OT-58 recruiting patients with CBSDH
Read More
Sareum selects small-molecule inhibitor of TYK2/JAK1 for development for certain cancers
Read More
AI-powered platform for optimization of drug combination regimen in metastatic prostate cancer
Read More
Novavax opens phase II trial of NanoFlu
Read More
Vaccibody presents positive 6-month interim results from phase I/IIa study of VB10.16 immunotherapy
Read More
Eli Lilly and Company patents MAP3K5 inhibitors
Read More
Prelude Therapeutics divulges new PRMT5 inhibitors
Read More
Aldeyra announces positive data from phase IIb study of reproxalap topical ophthalmic solution
Read More
3M Pharmaceuticals synthesizes new cytokine biosynthesis inducers
Read More
Lupin identifies SCN9A blockers
Read More
Patient recruitment starts in phase III study of Ameluz plus BF-RhodoLED in superficial BCC
Read More
Lycera patents RORC agonists as IL-17 production enhancers
Read More
PAF-R antagonist XQ-1H well tolerated in phase I study
Read More
BriaCell achieves proof of concept with Bria-IMT in phase IIa breast cancer study
Read More
Newly developed ISOD mouse model mimics human disease
Read More
Janssen initiates phase III trial of guselkumab in pediatric psoriasis
Read More
Concert Pharmaceuticals amends protocol of phase IIa trial with CTP-543 in alopecia areata
Read More
Targovax reports interim tumor response data from phase I study of ONCOS-102 in advanced melanoma
Read More
MKP-5 inhibition as a novel therapeutic target for lung fibrosis
Read More
Discovery of novel Ref-1 inhibitors with the ability to block ocular neovascularization
Read More
Researchers develop viable murine model of cblC deficiency
Read More
